HeartRhythm

APRIL 30, 2024

Ventricular tachycardia (VT) ablation in structural heart disease improves arrhythmia free survival. Procedural factors that influence these outcomes are not well described.

Arrhythmia 40

Arrhythmia Ablation Electrophysiology Outcomes 40

Journal of Cardiovascular Electrophysiology

JANUARY 24, 2025

ABSTRACT Introduction Data regarding safety and long-term outcome of very high-power-short duration (vHPSD) ablation in adult congenital heart disease (ACHD) patients with paroxysmal or persistent atrial fibrillation (AF) are lacking. Methods Retrospective observational single-center study. with paroxysmal AF, 43.6%

Congenital Heart Disease 40

Congenital Heart Disease Atrial Fibrillation Congenital Ablation 40

Conquering CHD

JUNE 20, 2023

Congenital heart disease is a daunting diagnosis for any parent. We’ll cover common types of medications used to treat congenital heart disease, what parents should know about their use, and potential side effects to watch out for. Be sure to talk to your doctor if you have any questions or concerns.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease ACE Inhibitor 52

HeartRhythm

APRIL 30, 2024

Multiple risk factors for arrhythmia recurrence after Ventricular Tachycardia (VT) ablation have been identified. However, the cumulative impact of these risk factors has not been evaluated, making it challenging to predict these risks in patients with multiple coexisting conditions.

Tachycardia 40

Tachycardia Ablation Risk Factors Heart Disease 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 7, 2024

ABSTRACT Introduction The aim of this study was to describe our experience and outcome of ablation therapy for arrhythmias in pediatrics at a tertiary care center. The data collected included type of arrhythmia, ablation technique, age and weight at ablation, procedure complications, medications used, and outcome assessment.

Pediatrics 40

Pediatrics Ablation Tachycardia Arrhythmia 40

MIBHS

JANUARY 31, 2025

Among their many benefits, wearable tech has proven to be a game-changer in monitoring heart health, particularly for individuals managing cardiovascular conditions or preparing for minimally invasive or bloodless heart surgery. Sleep Monitoring Quality sleep is essential for heart health.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

Journal of the American Heart Association

FEBRUARY 14, 2025

Journal of the American Heart Association, Ahead of Print. BackgroundIschemic cardiomyopathy (ICM) is the end stage of ischemic heart disease, in which ventricular remodeling contributes to a fatal ventricular arrhythmia, worsens heart function and unfavorable outcomes, and is related to persistent chronic inflammation.

Electrophysiology 45

Electrophysiology Ultrasound Cardiomyopathy Arrhythmia 45

Circulation: Arrhythmia and Electrophysiology

JUNE 5, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Epicardial approach in ventricular tachycardia (VT) ablation is still regarded as a second-step strategy, due to the risk of complications. The epicardial approach was considered useful if epicardial ablation was performed after epicardial mapping.

Ablation 40

Ablation Tachycardia Heart Disease Cardiomyopathy 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 12, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:A growing number of patients with tetralogy of Fallot develop left ventricular systolic dysfunction and heart failure, in addition to right ventricular dysfunction. years) with tetralogy of Fallot and CRT were enrolled.

Congenital Heart Disease 40

Congenital Heart Disease Outcomes Electrophysiology Congenital 40

GEMMS

MAY 22, 2024

Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. This improves diagnostic accuracy and ultimately leads to better patient outcomes.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 7, 2024

Catheter ablation of atrial fibrillation in infiltrative cardiomyopathies ABSTRACT Atrial and ventricular arrhythmias are common in patients with Infiltrative heart diseases. AF is the most common arrhythmia identified in patients with amyloidosis due to cellular infiltration and atrial dilation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Cardiomyopathy Arrhythmia 40

MIBHS

NOVEMBER 30, 2023

Mental Health And Heart Health The complex relationship between mental health and heart health highlights the ways in which our emotional well-being can significantly influence the cardiovascular system. Research has shown that individuals with depression are more likely to develop heart disease.

Blood Pressure 52

Blood Pressure Heart Disease Blood Clot Physiology 52

Journal of Cardiovascular Pharmacology

FEBRUARY 26, 2025

Immuno-cardiology is an emerging field that explores the interplay between the immune system, inflammation and cardiovascular health/disease, aiming to develop innovative therapies for preventing and treating cardiac diseases. Copyright 2025 Wolters Kluwer Health, Inc. All rights reserved.

Pharmacology 40

Pharmacology Quality of Life Innovation Technology 40

DAIC

DECEMBER 19, 2023

OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. FACC, FHRS, FHSC , Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. billion (2). Kingshott, R.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

Vector Remote

APRIL 14, 2023

Much like how the history of cardiac remote monitoring began, the aim was to provide better healthcare services to improve patient outcomes. These remote monitoring capabilities quickly advanced and gave physicians access to patient data for more immediate and accurate diagnosis and treatment of arrhythmias.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

Cardiometabolic Health Congress

AUGUST 30, 2024

This discussion explores the principles and practices of evidence-based cardiometabolic medicine, emphasizing the importance of integrating the latest research findings into clinical decision-making to improve patient outcomes.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52

Wellnest

JUNE 19, 2023

India is witnessing a rise in Coronary heart disease (CHD). brings a new era of personalized medicine, enabling early detection of diseases, precise risk assessment, and tailored interventions. It transforms how healthcare services are delivered, improving outcomes and optimizing resources. For instance: 1.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

Ken Grauer, MD

FEBRUARY 28, 2023

C ardiac M anifestations of C ovid-19: Manifestations of heart disease may be seen in patients with Covid-19, including signs of myocardial injury.

Blog 78

Blog COVID-19 AFIB Pulmonary 78

MIBHS

FEBRUARY 28, 2025

Heart disease remains one of the leading causes of death worldwide, often attributed to a mix of lifestyle choices, environmental factors, and genetic predispositions. Understanding the Genetic Connection to Heart Disease Your genetic makeup plays a vital role in shaping your heart health.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

Dr. Smith's ECG Blog

JUNE 1, 2020

Classification of the morphologic type of VT may provide clues to etiology, outcome and treatment. Monomorphic VT may occur in patients with or without underlying structural heart disease. Patients with pleomorphic VT generally have significant underlying structural heart disease. Smith’s ECG Blog ( See text ).

Tachycardia 52

Tachycardia AFIB Blog Heart Disease 52

Open Heart

JANUARY 19, 2025

Introduction Data on the characteristics and outcomes of pregnancy and among patients with Fontan physiology are limited. We aimed to evaluate the immediate and long-term outcomes among these patients who were followed at our centre. We examined maternal and obstetric outcomes.

Congenital Heart Disease 52

Congenital Heart Disease Outcomes Physiology Arrhythmia 52

Dr. Smith's ECG Blog

MAY 14, 2022

Outcome Electrophysiologic study showed an accessory pathway (WPW, antidromic AVRT) Why did adenosine not work? Our electrophysiologist, Rehan Karim, explains: " At this HR in general one might expect overall transit time for any IV drug to be very slow to reach the heart. 6 mg often does not work, but especially in low flow states.

Tachycardia 52

Tachycardia Electrophysiology Blog Ablation 52

Frontiers in Cardiovascular Medicine

JUNE 3, 2024

The prevalence of congenital heart disease (CHD) in adult patients has risen with advances in diagnostic and surgical techniques. Patients with CHD commonly experience both supraventricular and ventricular arrhythmias, with each CHD type associated with different arrhythmia patterns.

Congenital Heart Disease 81

Congenital Heart Disease Congenital Heart Disease Arrhythmia 81

Dr. Smith's ECG Blog

AUGUST 9, 2024

There are three mechanisms of arrhythmia: automatic, re-entry, and triggered. The most common triggered arrhythmia is Torsades de Pointes. It is a benign arrhythmia which requires no specific treatment. Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion. Do not treat AIVR.

Chest Pain 106

Chest Pain Arrhythmia Myocardial Infarction STEMI 106

Open Heart

JANUARY 18, 2024

Objective Residual sequelae after surgical repair of tetralogy of Fallot (rTOF) affect clinical outcome. Methods Patients from the Swiss Adult Congenital HEart disease Registry were included. NT-proBNP, right atrial area and peak heart rate were independent predictors of outcomes.

Congenital Heart Disease 92

Congenital Heart Disease Congenital Heart Failure Exercise 92

HeartRhythm

APRIL 30, 2024

Inherited arrhythmias (IAs) account for a significant proportion of sudden cardiac death (SCD) in young patients without overt heart disease. Recent studies have suggested that substantial proportion of IAs is much prevalent in East Asian people. To date, the studies of Asian pediatric population with IAs are rarely reported.

Pediatrics 40

Pediatrics Sudden Cardiac Death Arrhythmia Heart Disease 40

Open Heart

AUGUST 7, 2023

Objective Ebstein’s anomaly is a rare congenital cardiac condition and data regarding pregnancy outcomes in this patient group are scarce. Methods The Registry of Pregnancy and Cardiac disease is a prospective global registry of pregnancies in women with structural cardiac disease. Neonatal mortality was 2.5%

Outcomes 40

Outcomes Congenital Heart Disease Tricuspid Heart Failure 40

ADN Center of Excellence

SEPTEMBER 28, 2023

The aim of this day is to encourage individuals and healthcare professionals, particularly cardiologists, to take proactive measures in preventing heart diseases. The Role of Cardiologists Cardiologists are at the forefront of the battle against heart diseases.

COVID-19 52

COVID-19 Heart Disease Education Interventional Cardiology 52

Journal of the American Heart Association

MARCH 4, 2025

An increasing number of studies have shown the impact of social determinants of health (SDoHs) on different cardiovascular outcomes. In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Congenital Heart Disease Coronary Artery Disease 40

Cardiometabolic Health Congress

AUGUST 8, 2024

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. 4 Keys To Partnering With Patients: The Cornerstone of Effective Cardiorenal Metabolic Management At the heart of any successful healthcare intervention lies the patient.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

American College of Cardiology

FEBRUARY 1, 2025

The simple test revealed Wolff-Parkinson-White syndrome, an easily diagnosable and treatable arrhythmia. "I That experience in the late 1990s spurred Volgman to create the Rush Heart Center for Women in Chicago in 2003, one of the first dedicated women's heart programs in the country. "In

Cardiovascular Disease 43

Cardiovascular Disease Education Coronary Artery Disease Risk Factors 43

Dr. Smith's ECG Blog

APRIL 8, 2015

Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS. The most recent and probably best study is this: Canadian Syncope Arrhythmia Risk Score. h/o heart disease (+1) 3.

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

Circulation

NOVEMBER 11, 2024

Introduction:Atrial fibrillation (AF) is a common cardiac arrhythmia, the risk of cardiovascular adverse outcome rises when it coexists with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI).

Atrial Fibrillation 40

Atrial Fibrillation Coronary Artery Bypass Graft Coronary Artery Disease Myocardial Infarction 40

Dr. S. Venkatesan MD

APRIL 3, 2025

In pregnant women with significant heart disease : A quick LSCS or a potentially prolonged natural delivery,which is more safe ? For women with significant heart disease (e.g., In women with significant heart disease, the physiological demands of labor (e.g., Is LSCS really more safe ?

Heart Disease 45

Heart Disease Blood Pressure Heart Failure Aortic 45

DAIC

OCTOBER 30, 2024

"The Affera system provides physicians with one safe, effective and efficient solution to this common and increasing problem in heart disease that needs optimized solutions for patients. Director of Cardiac Arrhythmia Services for the Mount Sinai Health System in New York City. The potential of Affera is limitless.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52

AMS Cardiology

APRIL 10, 2025

Regular checkups are one of the most effective ways to protect your long-term heart healthand at AMS Cardiology, we make the process easy. Understanding how to avoid heart disease starts with us. Catch Heart Issues Before They Start Heart disease doesnt happen overnight. Think again.

Blood Pressure 40

Blood Pressure Heart Disease Cholesterol Coronary Artery Disease 40